bristol myers squibb

2 min read 2022-06-03 22:50:16

Merck KGaA strikes $550 million deal with proxygen in latest protein degradation deal

Merck KGaA strikes $550M deal with proxygen in latest protein degradation deal Published: Jun 03, 2022 By Alex Keown BioSpace Protein degradation

1 min read 2022-06-03 03:48:08

Bristol Myers, J&J drugs reduce COVID death rates in NIH study June 2, 2022; 12:47 PM EDT (Reuters) – A late-stage study of two rheumatoid

2 min read 2022-06-01 23:26:25

BMS preps lupus treatment to become third approval in space Published: Jun 01, 2022 By Hayley Shasteen BioSpace Bristol Myers Squibb (BMS)

3 min read 2022-05-31 23:08:48

BMS, Novartis and Roche score new approvals for key drugs Published: May 31, 2022 By Vanessa Doctor, RN BioSpace The long weekend saw three

2 min read 2022-05-27 22:55:34

Genentech announces optimistic data in aggressive DLBCL Published: May 27, 2022 By Haley Shasteen BioSpace Genentech, a member of the

1 min read 2022-05-24 18:00:06

Pfizer ulcerative colitis drug leads to remission in a third of patients – study May 24, 2022, 6:50 AM EDT By Michael Erman (Reuters) –

4 min read 2022-05-16 23:45:00

When you make food for yourself, there’s never much harm in experimenting. Even if you completely screw up the recipe, you can probably still eat

2 min read 2022-05-16 21:59:36

BMS, Synairgen regroup after trials miss primary endpoints Published: May 16, 2022 By Jazmine Colatriano M.S. BioSpace Monday woes were shared by

2 min read 2022-05-13 21:21:03

BridgeBio augments comeback week with sale of priority review voucher Published: May 13, 2022 By Alex Keown BioSpace One day after BridgeBio

2 min read 2022-05-12 22:52:52

BMS & BridgeBio team up in nearly $1B oncology pact Published: May 12, 2022 By Vanessa Doctor, MS BioSpace BridgeBio announced that it

2 min read 2022-05-11 20:00:05

Blow to Roche’s cancer immunotherapy prospects as 2nd trial fails May 11, 2022, 8:51 AM EDT By Ludwig Burger FRANKFURT, May 11 (Reuters) –

2 min read 2022-05-05 04:50:20

BMS and Merck Buy Big Into Amphista’s Protein Degradation Platform Published: May 04, 2022 By Alex Keown BioSpace Amphista Therapeutics has

1 min read 2022-04-29 10:56:01

FDA approves Bristol Myers’ oral heart disease drug April 28, 2022; 10:09 PM EDT (Reuters) – Bristol Myers Squibb (BMY.N) said on Thursday the

3 min read 2022-04-26 22:08:52

Nektar Cuts 70% of Workforce on Heels of BMS-Partnered Collapse Published: Apr 26, 2022 By Mark Terry BioSpace On Monday, Nektar Therapeutics

1 min read 2022-04-15 06:32:54

Nektar stops clinical trials for key cancer drug, shares tumble April 14, 2022; 7:19 PM EDT (Reuters) – Nektar Therapeutics said on Thursday it had